Abstract
InCytu, Inc. is an applied biotechnology company developing cell therapy delivery devices that promote targeted tissue healing/regeneration or modulate the immune system.
Financial & competing interests disclosure
The authors are employees of InCytu. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.